about
DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS.MINIMALLY INVASIVE SURGERY FOR GASTRIC CANCER: TIME TO CHANGE THE PARADIGMDetection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysisLymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status.Endoscopic stent for treatment of esophagojejunostomy fistula.GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE.Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment.Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis.Minimally invasive surgery for gastric cancer in Brazil: current status and perspectives-a report from the Brazilian Laparoscopic Oncologic Gastrectomy Group (BLOGG)Validation of classic and expanded criteria for endoscopic submucosal dissection of early gastric cancer: 7 years of experience in a Western tertiary cancer centerRisk factors associated with the development of gastric cancer - case-control studySurgical treatment of gastric cancer: a 10-year experience in a high-volume university hospitalAssociation between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric CancerTOTAL OMENTECTOMY IN GASTRIC CANCER SURGERY: IS IT ALWAYS NECESSARY?CONVERSION THERAPY FOR GASTRIC CANCER: EXPANDING THE TREATMENT POSSIBILITIESNeutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancerDuodenal fistula: The most lethal surgical complication in a case series of radical gastrectomyReply to: "Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer"Multivisceral resection vs standard gastrectomy for gastric adenocarcinomaLaparoscopic D2 Gastrectomy for Gastric Cancer: Mid-Term Results and Current EvidenceGastric cancer in young adults: a worse prognosis group?Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteriaExpression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer PatientsSchistosomiasis Misleading Gastric Cancer TreatmentLymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancerNeutrophil-lymphocyte ratio change after curative gastrectomy for gastric cancer: a subgroup analysisGastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?MINIMALLY INVASIVE SURGERY FOR GASTRIC CANCER: PARADIGM SHIFTGastric partitioning for the treatment of malignant gastric outlet obstructionEsophagojejunal anastomotic fistula: a major issue after radical total gastrectomyImpact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control studyOncological Robot-Assisted Gastrectomy: Technical Aspects and Ongoing DataPrediction scores for complication and recurrence after multivisceral resection in gastric cancerSurgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditionsImmunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy
P50
Q33656066-DF45AC88-E00C-44D1-8DDF-FB5959675083Q36082769-F0EC3AB1-472E-48ED-9EA9-102A6E7391BBQ39079745-A15624FB-FD63-455F-8836-406424ACFEC1Q40221398-38941F65-4CF9-4896-9EA5-CBA1E0E8FDA4Q42545022-4726AFF0-BCC8-4E56-9B8F-3891964C04E5Q47116429-C9E6F499-FEB6-4052-BF48-8A1FBF70321BQ48326847-A0D5A9A2-E15F-4666-BC43-8BA593EE75FBQ54256783-F729F7B6-417D-4DC0-8AB5-0452E145C97FQ55135821-50235F7E-8A20-4544-A4B6-7DA6464D72E8Q57218292-0C0569D1-7EF7-4CDB-A8CD-27C4A1619151Q57475459-4AE13E3D-271E-427D-BF91-152D0FCE39E5Q58571338-C59972D7-DF6F-49E9-BA1E-2FB0115DDAD1Q59806717-057F7EDD-31D4-4760-BAFD-A55BA472B82CQ60956827-D79C7A57-B755-44C7-8373-AFB34682D1D2Q61797720-BCC49E36-1A1B-4B19-97FE-48E19220058EQ64080759-3764FD8A-BE39-476C-9CF7-BBA7797D7840Q87978361-93F60EBA-D8A9-4CA3-AF17-93D3E4018D27Q88352691-C2B7B1A8-60FB-42E9-AC83-F7D8330D3682Q89022810-7CDE9D0B-43B1-43B5-AF29-B00493B34427Q89463449-CA9AA6DC-6765-405B-84DF-DE935A9F8D7AQ90335380-B63E9351-8F0A-4083-A280-372E2B801786Q90433293-6294C21D-8660-4788-A626-DBDA1E53A492Q90573100-47000819-F06F-4462-9237-2C99A218B7E9Q90600978-0ADA2AC3-53BE-41DD-94B7-8EDF5ED11BCAQ91348475-8AA7702E-1904-4E9E-A6EA-A61CF941FB3BQ91407068-3B56F211-4C25-4BB3-8F93-A517BCC81C7CQ91482360-C81F6179-83DB-4192-B1A2-E2566B3F6E69Q91508111-E7F591B1-8AB0-4EC6-8E16-B70A85DE57E7Q91661894-572D7027-2F24-4C3C-8D7D-1A69134F8332Q92146645-87490EC9-68D0-4C14-8B72-252DB0C2E8B0Q92462644-E884EB73-8047-4E8D-8674-D5BAF08EEB19Q92507494-C63D1AF3-809D-44F7-8360-EF05D4FDDF30Q92676146-50ECCB32-4C67-45C8-B430-880FBAB1B74EQ92896788-753B1416-E947-4E2D-838F-26EBD901984AQ92974523-D4D91AB6-0DFE-4E2E-B7D7-59D904633472Q93375203-C5CC8490-18F3-4ADB-AD54-C154427115C9Q95360016-3049EE41-8D14-4C3E-9277-EA2F8502D6BE
P50
description
researcher ORCID ID = 0000-0003-0200-7858
@en
wetenschapper
@nl
name
Marcus Fernando Kodama Pertille Ramos
@ast
Marcus Fernando Kodama Pertille Ramos
@en
Marcus Fernando Kodama Pertille Ramos
@es
Marcus Fernando Kodama Pertille Ramos
@nl
type
label
Marcus Fernando Kodama Pertille Ramos
@ast
Marcus Fernando Kodama Pertille Ramos
@en
Marcus Fernando Kodama Pertille Ramos
@es
Marcus Fernando Kodama Pertille Ramos
@nl
prefLabel
Marcus Fernando Kodama Pertille Ramos
@ast
Marcus Fernando Kodama Pertille Ramos
@en
Marcus Fernando Kodama Pertille Ramos
@es
Marcus Fernando Kodama Pertille Ramos
@nl
P106
P1153
57192279546
P31
P496
0000-0003-0200-7858